{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:34:03Z","timestamp":1793846043693,"version":"4.6.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"GSK, London, UK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40121-026-01346-z","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:16:43Z","timestamp":1776381403000},"page":"1589-1606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiology of Acute Cystitis or Afebrile Urinary Tract Infection in Adult Men: A Systematic Literature Review"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6225-2164","authenticated-orcid":false,"given":"Mary E.","family":"Georgiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Wittkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison T.","family":"Preib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish V.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruni","family":"Mulgirigama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny S.","family":"Mitrani-Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"1346_CR1","doi-asserted-by":"publisher","DOI":"10.1177\/1756287219832172","volume":"11","author":"M Medina","year":"2019","unstructured":"Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:1756287219832172. https:\/\/doi.org\/10.1177\/1756287219832172.","journal-title":"Ther Adv Urol"},{"key":"1346_CR2","unstructured":"Cairns C, Kang K, Santo L. National hospital ambulatory medical care survey: 2018 emergency department summary tables. 2018. https:\/\/www.cdc.gov\/nchs\/data\/nhamcs\/web_tables\/2018-ed-web-tables-508.pdf. Accessed 17 June 2025."},{"issue":"10","key":"1346_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41585-020-0362-4","volume":"17","author":"FME Wagenlehner","year":"2020","unstructured":"Wagenlehner FME, Bjerklund Johansen TE, Cai T, et\u00a0al. Epidemiology, definition and treatment of complicated urinary tract infections. Nat Rev Urol. 2020;17(10):586\u2013600. https:\/\/doi.org\/10.1038\/s41585-020-0362-4.","journal-title":"Nat Rev Urol"},{"key":"1346_CR4","unstructured":"FDA. Uncomplicated urinary tract infections: developing drugs for treatment guidance for industry. 2019. https:\/\/www.fda.gov\/media\/129531\/download. Accessed 17 June 2025."},{"key":"1346_CR5","unstructured":"EAU. Eau guidelines on urological infections. 2024. https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Urological-Infections-2024.pdf. Accessed 17 June 2025."},{"key":"1346_CR6","unstructured":"FDA. Complicated urinary tract infections: developing drugs for treatment guidance for industry. 2018. https:\/\/www.fda.gov\/media\/71313\/download. Accessed 17 June 2025."},{"key":"1346_CR7","first-page":"19","volume":"1","author":"A Craig","year":"2023","unstructured":"Craig A. A preview of clinical practice guideline updates. Microbiol Infect Dis AMJ. 2023;1:19\u201321.","journal-title":"Microbiol Infect Dis AMJ"},{"key":"1346_CR8","unstructured":"Bono MJ, Leslie SW, Reygaert WC. Uncomplicated urinary tract infections. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2024."},{"issue":"1","key":"1346_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.ajkd.2023.08.009","volume":"83","author":"H Al Lawati","year":"2024","unstructured":"Al Lawati H, Blair BM, Larnard J. Urinary tract infections: core curriculum 2024. Am J Kidney Dis. 2024;83(1):90\u2013100. https:\/\/doi.org\/10.1053\/j.ajkd.2023.08.009.","journal-title":"Am J Kidney Dis"},{"issue":"1154","key":"1346_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1136\/postgradmedj-2020-139090","volume":"97","author":"R Kaur","year":"2021","unstructured":"Kaur R, Kaur R. Symptoms, risk factors, diagnosis and treatment of urinary tract infections. Postgrad Med J. 2021;97(1154):803\u201312. https:\/\/doi.org\/10.1136\/postgradmedj-2020-139090.","journal-title":"Postgrad Med J"},{"key":"1346_CR11","unstructured":"Pendegast HJ, Leslie SW, Rosario DJ. Chronic prostatitis and chronic pelvic pain syndrome in men. eds. Statpearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.: 2025"},{"key":"1346_CR12","unstructured":"IDSA. Complicated urinary tract infections (cuti): Clinical guidelines for treatment and management. 2025. https:\/\/www.idsociety.org\/practice-guideline\/complicated-urinary-tract-infections\/. Accessed 29 July 2025."},{"key":"1346_CR13","unstructured":"NICE. Urinary tract infection (lower) - men: How common is it? 2025. https:\/\/cks.nice.org.uk\/topics\/urinary-tract-infection-lower-men\/background-information\/prevalence\/. Accessed 17 June 2025."},{"key":"1346_CR14","unstructured":"Higgins JPT, Thomas J, Chandler J, et\u00a0al. Cochrane handbook for systematic reviews of interventions version 6.1 (updated september 2020). 2019. https:\/\/training.cochrane.org\/handbook\/archive\/v6.1. Accessed 17 June 2025."},{"issue":"1","key":"1346_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09946-8","volume":"12","author":"M Takahashi","year":"2022","unstructured":"Takahashi M, Hagiya H, Higashionna T, et\u00a0al. Antimicrobial prescription practices for outpatients with uncomplicated cystitis in Japan. Sci Rep. 2022;12(1):5921. https:\/\/doi.org\/10.1038\/s41598-022-09946-8.","journal-title":"Sci Rep"},{"issue":"728","key":"1346_CR16","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.3399\/bjgp.2022.0354","volume":"73","author":"TN Platteel","year":"2023","unstructured":"Platteel TN, Beets MT, Teeuwissen HA, et\u00a0al. Nitrofurantoin failure in males with an uncomplicated urinary tract infection: a primary care observational cohort study. Br J Gen Pract. 2023;73(728):e204\u201310. https:\/\/doi.org\/10.3399\/bjgp.2022.0354.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"1346_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.20471\/acc.2016.55.01.8.","volume":"55","author":"O Guneysel","year":"2016","unstructured":"Guneysel O, Suman E, Ozturk TC. Trimethoprim-sulfamethoxazole resistance and fosfomycin susceptibility rates in uncomplicated urinary tract infections: time to change the antimicrobial preferences. Acta Clin Croat. 2016;55(1):49\u201357. https:\/\/doi.org\/10.20471\/acc.2016.55.01.8.","journal-title":"Acta Clin Croat"},{"issue":"1","key":"1346_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06865-3","volume":"21","author":"G Abongomera","year":"2021","unstructured":"Abongomera G, Koller M, Musaazi J, et\u00a0al. Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study. BMC Infect Dis. 2021;21(1):1179. https:\/\/doi.org\/10.1186\/s12879-021-06865-3.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"1346_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/jama.2021.9899","volume":"326","author":"DM Drekonja","year":"2021","unstructured":"Drekonja DM, Trautner B, Amundson C, Kuskowski M, Johnson JR. Effect of 7 vs 14 days of antibiotic therapy on resolution of symptoms among afebrile men with urinary tract infection: a randomized clinical trial. JAMA. 2021;326(4):324\u201331. https:\/\/doi.org\/10.1001\/jama.2021.9899.","journal-title":"JAMA"},{"issue":"8","key":"1346_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9080511","volume":"9","author":"M Fajfr","year":"2020","unstructured":"Fajfr M, Balik M, Cermakova E, Bostik P. Effective treatment for uncomplicated urinary tract infections with oral fosfomycin, single center four year retrospective study. Antibiotics Basel. 2020;9(8):511. https:\/\/doi.org\/10.3390\/antibiotics9080511.","journal-title":"Antibiotics Basel"},{"key":"1346_CR21","unstructured":"ICDLIST. 2025 icd-10-cm diagnosis code n30.00 acute cystitis without hematuria. 2025. https:\/\/icdlist.com\/icd-10\/N30.00. Accessed 20 Aug 2025."},{"key":"1346_CR22","unstructured":"AUA. Updates to recurrent uncomplicated urinary tract infections in women: Aua\/cua\/sufu guideline (2025). 2025. https:\/\/www.auanet.org\/guidelines-and-quality\/guidelines\/recurrent-uti. Accessed 23 Oct 2025."},{"key":"1346_CR23","doi-asserted-by":"crossref","unstructured":"Frisbie L, Weissman SJ, Kapoor H, et\u00a0al. Antimicrobial resistance patterns of urinary Escherichia coli among outpatients in Washington state, 2013\u20132017: associations with age and sex. 2021;73(6):1066\u201374.","DOI":"10.1093\/cid\/ciab250"},{"key":"1346_CR24","doi-asserted-by":"crossref","unstructured":"Salm J, Salm F, Arendarski P, Kramer TSJE. High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020. 2022;27(30):2101012.","DOI":"10.2807\/1560-7917.ES.2022.27.30.2101012"},{"key":"1346_CR25","doi-asserted-by":"publisher","unstructured":"OECD. Stemming the superbug tide: just a few dollars more, OECD Health Policy Studies. Paris: OECD Publishing. 2018. https:\/\/doi.org\/10.1787\/9789264307599-en.","DOI":"10.1787\/9789264307599-en"},{"key":"1346_CR26","doi-asserted-by":"publisher","unstructured":"OECD. Embracing a one health framework to fight antimicrobial resistance, OECD Health Policy Studies. Paris: OECD Publishing. 2023. https:\/\/doi.org\/10.1787\/ce44c755-en.","DOI":"10.1787\/ce44c755-en"},{"key":"1346_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jgar.2020.08.025","volume":"23","author":"F Campanile","year":"2020","unstructured":"Campanile F, Wootton M, Davies L, et\u00a0al. Gold standard susceptibility testing of fosfomycin in Staphylococcus aureus and enterobacterales using a new agar dilution panel\u00ae. J Glob Antimicrob Resist. 2020;23:334\u20137. https:\/\/doi.org\/10.1016\/j.jgar.2020.08.025.","journal-title":"J Glob Antimicrob Resist"},{"key":"1346_CR28","unstructured":"Aggarwal N, Leslie S, Lotfollahzadeh SJS. Recurrent urinary tract infections. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing: 2024."},{"issue":"21","key":"1346_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3238\/arztebl.2010.0361","volume":"107","author":"G Schmiemann","year":"2010","unstructured":"Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E. The diagnosis of urinary tract infection: a systematic review. Dtsch Arztebl Int. 2010;107(21):361\u20137. https:\/\/doi.org\/10.3238\/arztebl.2010.0361.","journal-title":"Dtsch Arztebl Int"},{"key":"1346_CR30","doi-asserted-by":"publisher","DOI":"10.2217\/ahe.13.38.","author":"TA Rowe","year":"2013","unstructured":"Rowe TA, Juthani-Mehta M. Urinary tract infection in older adults. Aging health. 2013. https:\/\/doi.org\/10.2217\/ahe.13.38.","journal-title":"Aging health"},{"issue":"5","key":"1346_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269\u201384. https:\/\/doi.org\/10.1038\/nrmicro3432.","journal-title":"Nat Rev Microbiol"},{"key":"1346_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310537.","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhou Z, Zheng L, et\u00a0al. Urinary tract infections caused by uropathogenic Escherichia coli: mechanisms of infection and treatment options. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241310537.","journal-title":"Int J Mol Sci"},{"key":"1346_CR33","unstructured":"NICE. Urinary tract infection (lower)\u2014men: What causes urinary tract infections? 2025. https:\/\/cks.nice.org.uk\/topics\/urinary-tract-infection-lower-men\/background-information\/causes\/. Accessed 18 July 2025."},{"key":"1346_CR34","unstructured":"NICE. Urinary tract infection (lower) - women: What causes it? 2025. https:\/\/cks.nice.org.uk\/topics\/urinary-tract-infection-lower-women\/background-information\/causes\/. Accessed 18 July 2025."}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01346-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01346-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01346-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:50:42Z","timestamp":1779972642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01346-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1346"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01346-z","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mary E. Georgiou, Fanny S. Mitrani-Gold, Madison T. Preib, Ashish V. Joshi, and Aruni Mulgirigama are employed by GSK, and hold financial equities in GSK. Priscilla Wittkopf, Amber L. Martin, and Joanna Kamar are employed by Evidera, which received funding from GSK for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}